Beauty Farm Medical and Health Industry Inc. disclosed a minor on-market share repurchase on 15 May 2026, acquiring 23,000 ordinary shares at prices between HKD 18.87 and HKD 19.24. The volume-weighted average repurchase price was HKD 19.06, for a total consideration of approximately HKD 0.44 million.

Post-transaction, issued shares outstanding (excluding treasury shares) decreased to 249.49 million, representing a 0.0092% contraction. Treasury shares rose correspondingly to 2.10 million, leaving total issued shares unchanged at 251.59 million.

The buyback forms part of the mandate approved on 27 June 2025, which authorises repurchases of up to 23.58 million shares. Following the latest transaction, cumulative buybacks under this mandate stand at 2.10 million shares, equivalent to 0.89% of the share base on the mandate date, leaving significant capacity for further repurchases.

All repurchased shares are being held in treasury. In accordance with Hong Kong listing rules, Beauty Farm is subject to a moratorium on issuing new shares or disposing of treasury shares until 14 June 2026.